S

SGB

7 employees

VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2006

Funding rounds raised

Total raised

$51M

from 9 investors over 9 rounds

S

SGB raised $51M on September 23, 2014

Investors: ARCH Venture Partners, Frazier Healthcare Partners and Celgene

S

SGB raised $25M on January 13, 2010

Investors: Frazier Healthcare Partners, Domain Associates and ARCH Venture Partners

S

SGB raised $27M on March 6, 2007

Investors: Domain Associates, Frazier Healthcare Partners and ARCH Venture Partners

FAQ